D. Verver
Impact in
- Oncology top 10%
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
-
- Endometrial and Cervical Cancer Treatments
Papers in
- Oncology 20
- Cutaneous Melanoma Detection and Management 16
- CAR-T cell therapy research 6
- Cancer Immunotherapy and Biomarkers 2
-
- Melanoma and MAPK Pathways 4
- Viral Infectious Diseases and Gene Expression in Insects 1
- Co-authors
- Cornelis Verhoef (19 shared papers)Dirk J. Grünhagen (18 shared papers)Alexander C. J. van Akkooi (10 shared papers)Jan N.M. IJzermans (2 shared papers)Shiromani Janki (2 shared papers)Astrid A.M. van der Veldt (9 shared papers)Rudolf Stadler (2 shared papers)Ulrike Leiter (2 shared papers)
- Journals
- European Journal of Surgical Oncology (4 papers)European Journal of Cancer (3 papers)British journal of surgery (2 papers)European Journal of Nuclear Medicine and Molecular Imaging (1 paper)Journal of Surgical Oncology (1 paper)
- Partner nations
- NetherlandsGermanyFrance
In The Last Decade
D. Verver
24 papers receiving 515 citations
Peers
Comparison fields: 5 of 49
- Oncology 359
- Obstetrics and Gynecology 23
- Biophysics 16
- Epidemiology 72
- Physiology 46
Countries citing papers authored by D. Verver
This map shows the geographic impact of D. Verver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Verver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Verver more than expected).
Fields of papers citing papers by D. Verver
This network shows the impact of papers produced by D. Verver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Verver. The network helps show where D. Verver may publish in the future.
Co-authors
The 25 scholars most cited alongside D. Verver, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 145 | |
| 2 | 2017 | 56 | |
| 3 | 2018 | 46 | |
| 4 | 2020 | 39 | |
| 5 | 2020 | 32 | |
| 6 | 2019 | 28 | |
| 7 | 2018 | 26 | |
| 8 | 2017 | 25 | |
| 9 | 2015 | 23 | |
| 10 | 2022 | 20 | |
| 11 | 2020 | 14 | |
| 12 | 2017 | 13 | |
| 13 | 2017 | 9 | |
| 14 | 2021 | 8 | |
| 15 | 2023 | 6 | |
| 16 | 2021 | 6 | |
| 17 | 2018 | 6 | |
| 18 | 2019 | 5 | |
| 19 | 2019 | 4 | |
| 20 | 2022 | 3 |
About D. Verver
D. Verver is a scholar working on Oncology, Molecular Biology, Surgery, Genetics and Immunology, having authored 26 papers that have together received 519 indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (16 papers), CAR-T cell therapy research (6 papers), Melanoma and MAPK Pathways (4 papers), Immunotherapy and Immune Responses (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Virus-based gene therapy research (2 papers), Cell Image Analysis Techniques (1 paper) and Viral Infectious Diseases and Gene Expression in Insects (1 paper). The work is most often cited by research in Oncology (359 citations), Obstetrics and Gynecology (23 citations), Biophysics (16 citations), Epidemiology (72 citations) and Physiology (46 citations). D. Verver has collaborated with scholars based in Netherlands, Germany and France. Frequent co-authors include Cornelis Verhoef, Dirk J. Grünhagen, Alexander C. J. van Akkooi, Jan N.M. IJzermans, Shiromani Janki, Astrid A.M. van der Veldt, Rudolf Stadler, Ulrike Leiter, Claus Garbe and Tamar Nijsten. Their work appears in journals such as European Journal of Surgical Oncology, European Journal of Cancer, British journal of surgery, European Journal of Nuclear Medicine and Molecular Imaging and Journal of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.